Biomarker for ovarian cancer
    1.
    发明申请
    Biomarker for ovarian cancer 审中-公开
    卵巢癌生物标志物

    公开(公告)号:US20070172902A1

    公开(公告)日:2007-07-26

    申请号:US11473280

    申请日:2006-06-21

    IPC分类号: G01N33/574 G06F19/00

    CPC分类号: G01N33/57449 G01N2333/52

    摘要: The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.

    摘要翻译: 本发明提供了一种可用于鉴定患者卵巢癌状态的基于蛋白质的生物标志物。 特别地,本发明的生物标志物可用于将受试者样品分类为卵巢癌或非卵巢癌。 可通过SELDI质谱法检测生物标志物。

    Biomarker for ovarian and endometrial cancer: hepcidin
    5.
    发明申请
    Biomarker for ovarian and endometrial cancer: hepcidin 有权
    卵巢和子宫内膜癌的生物标记物:铁调素

    公开(公告)号:US20070054329A1

    公开(公告)日:2007-03-08

    申请号:US11373833

    申请日:2006-03-10

    IPC分类号: G01N33/574

    摘要: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status as well as endometrical cancer status in a patient. In particular, it has been found that hepcidin is a biomarker for both ovarian cancer and endometrial cancer and that a panel of biomarkers, including hepcidin, transthyretin and optionally other markers are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.

    摘要翻译: 本发明提供了可用于鉴定卵巢癌状态以及患者中子宫内膜癌状态的基于蛋白质的生物标志物和生物标志物组合。 特别地,已经发现,铁调素是卵巢癌和子宫内膜癌的生物标志物,并且一组生物标志物,包括铁调素,转甲状腺素蛋白和任选的其他标记物可用于将受试者样品分类为卵巢癌或非卵巢癌。 生物标志物可以通过SELDI质谱检测。

    BIOMARKERS FOR OVARIAN CANCER
    6.
    发明申请
    BIOMARKERS FOR OVARIAN CANCER 有权
    OVARIAN癌症生物标志物

    公开(公告)号:US20120220476A1

    公开(公告)日:2012-08-30

    申请号:US13372137

    申请日:2012-02-13

    IPC分类号: C40B30/04 G06F19/10 C40B40/10

    CPC分类号: G06F19/34 G01N33/57449

    摘要: The present invention relates to a method of qualifying ovarian cancer status in a subject comprising: (a) measuring at least one biomarker in a sample from the subject and (b) correlating the measurement with ovarian cancer status. The invention further relates to kits for qualifying ovarian cancer status in a subject.

    摘要翻译: 本发明涉及一种在受试者中鉴定卵巢癌状态的方法,包括:(a)测量来自受试者的样品中的至少一种生物标志物,和(b)将测量与卵巢癌状态相关联。 本发明还涉及用于在受试者中鉴定卵巢癌状态的试剂盒。

    PANEL OF BIOMARKERS FOR OVARIAN CANCER
    7.
    发明申请
    PANEL OF BIOMARKERS FOR OVARIAN CANCER 审中-公开
    OVARIAN癌症生物标志物小组

    公开(公告)号:US20120046185A1

    公开(公告)日:2012-02-23

    申请号:US13204566

    申请日:2011-08-05

    CPC分类号: G01N33/57449

    摘要: The present invention provides a panel of protein-based biomarkers that are useful in diagnosing ovarian cancer in a subject. In particular, the panel of biomarkers of the invention are useful to classify a subject sample as having ovarian cancer or non-ovarian cancer.

    摘要翻译: 本发明提供了一组可用于诊断受试者卵巢癌的基于蛋白质的生物标志物。 特别地,本发明的生物标志物组对于将受试者样品分类为具有卵巢癌或非卵巢癌是有用的。

    Biomarkers for ovarian cancer
    8.
    发明授权
    Biomarkers for ovarian cancer 有权
    卵巢癌生物标记物

    公开(公告)号:US08682591B2

    公开(公告)日:2014-03-25

    申请号:US13372137

    申请日:2012-02-13

    CPC分类号: G06F19/34 G01N33/57449

    摘要: The present invention relates to a method of qualifying ovarian cancer status in a subject comprising: (a) measuring at least one biomarker in a sample from the subject and (b) correlating the measurement with ovarian cancer status. The invention further relates to kits for qualifying ovarian cancer status in a subject.

    摘要翻译: 本发明涉及一种在受试者中鉴定卵巢癌状态的方法,包括:(a)测量来自受试者的样品中的至少一种生物标志物,和(b)将测量与卵巢癌状态相关联。 本发明还涉及用于在受试者中鉴定卵巢癌状态的试剂盒。